Miller Anya, Hall Francis, Ahsan Syed
ENT of Denver, 4500 E. 9th Ave., Suite 610, Denver, CO 80220, USA.
Ear Nose Throat J. 2016 Oct-Nov;95(10-11):E26-E31.
The incidence of chronic otitis media with effusion (COME) after radiotherapy for nasopharyngeal or sinonasal tumors is relatively high. It is often a difficult-to-treat problem in these patients. In this retrospective study, we sought to describe the clinical course of COME in 51 patients-33 men and 18 women, aged 39 to 90 years (mean: 58.9 ± 15)-who had been referred to the Henry Ford Health System in Detroit between 2001 and 2011 for management of a tumor that had involved either the nasopharyngeal area or the sinonasal area. The median length of follow-up from the time of cancer diagnosis was 32 months. Of the 51 patients, 23 (45.1%) developed COME before, during, or after radiation therapy. Of these 23 patients, 13 (56.5%) did not experience any improvement after treatment with various combinations of therapies, including myringotomy, tympanostomy tube placement, otic drops, oral antibiotics, and corticosteroid nasal sprays. No patient- or tumor-specific factors were found to be significantly associated with the incidence of COME after irradiation to the sinonasal area. Older age and squamous cell tumor pathology were found to be significant factors for the resolution of COME after it had developed, whereas treatments with tympanostomy tubes and ear drops were not. Because of the high incidence of COME after radiotherapy and the high rate of COME's failure to resolve after tympanostomy tube insertion, we suggest that these patients require an alternative treatment.
鼻咽癌或鼻窦肿瘤放疗后中耳积液性慢性中耳炎(COME)的发病率相对较高。在这些患者中,这往往是一个难以治疗的问题。在这项回顾性研究中,我们试图描述51例患者(33例男性和18例女性,年龄39至90岁,平均58.9±15岁)COME的临床病程,这些患者在2001年至2011年间因鼻咽部或鼻窦区域肿瘤的治疗而转诊至底特律的亨利福特医疗系统。从癌症诊断时起的中位随访时间为32个月。51例患者中,23例(45.1%)在放疗前、放疗期间或放疗后发生COME。在这23例患者中,13例(56.5%)在接受包括鼓膜切开术、鼓膜置管术、滴耳剂、口服抗生素和糖皮质激素鼻喷雾剂等多种治疗组合后病情未得到任何改善。未发现任何患者或肿瘤特异性因素与鼻窦区域放疗后COME的发病率显著相关。年龄较大和鳞状细胞肿瘤病理类型被发现是COME发生后病情缓解的重要因素,而鼓膜置管术和滴耳剂治疗则不是。由于放疗后COME的高发病率以及鼓膜置管术后COME病情缓解的低成功率,我们建议这些患者需要替代治疗。